ICU Medical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

ICU Medical şirketinin kazançları yıllık ortalama -60.4% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 1.1% oranında azalan oldu. Gelirler yıllık ortalama 16.5% oranında artan oldu.

Anahtar bilgiler

-60.4%

Kazanç büyüme oranı

-60.1%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	4.3%
Gelir büyüme oranı	16.5%
Özkaynak getirisi	-5.4%
Net Marj	-4.7%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

ICU Medical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:IC7 Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Sep 24	2,340	-111	635	89
30 Jun 24	2,304	-71	620	89
31 Mar 24	2,257	-59	612	87
31 Dec 23	2,259	-30	607	85
30 Sep 23	2,249	-28	595	86
30 Jun 23	2,294	-48	600	89
31 Mar 23	2,306	-46	608	89
31 Dec 22	2,280	-74	608	93
30 Sep 22	2,043	-39	547	83
30 Jun 22	1,781	5	468	72
31 Mar 22	1,541	41	383	61
31 Dec 21	1,316	103	303	47
30 Sep 21	1,296	109	295	46
30 Jun 21	1,279	103	291	44
31 Mar 21	1,260	94	284	43
31 Dec 20	1,271	87	284	43
30 Sep 20	1,266	81	281	44
30 Jun 20	1,255	83	276	46
31 Mar 20	1,264	87	277	47
31 Dec 19	1,266	101	277	49
30 Sep 19	1,291	73	283	50
30 Jun 19	1,311	47	294	51
31 Mar 19	1,359	55	308	53
31 Dec 18	1,400	29	320	53
30 Sep 18	1,430	86	321	53
30 Jun 18	1,446	86	321	53
31 Mar 18	1,417	18	324	52
31 Dec 17	1,293	69	302	51
30 Sep 17	1,018	28	249	40
30 Jun 17	772	47	195	31
31 Mar 17	537	101	132	21
31 Dec 16	379	63	89	13
30 Sep 16	372	59	89	14
30 Jun 16	361	56	87	15
31 Mar 16	348	53	85	15
31 Dec 15	340	45	83	16
30 Sep 15	329	47	81	17
30 Jun 15	321	37	83	18
31 Mar 15	316	29	87	19
31 Dec 14	307	26	89	18
30 Sep 14	306	32	89	17
30 Jun 14	311	37	90	15
31 Mar 14	311	38	89	14
31 Dec 13	312	40	89	12

Kaliteli Kazançlar: IC7 şu anda kârlı değil.

Büyüyen Kar Marjı: IC7 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: IC7 kârlı değildir ve zararlar son 5 yılda yılda 60.4% oranında artmıştır.

Büyüme Hızlandırma: IC7 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: IC7 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 10.1% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: IC7 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -5.42% ) sahiptir.

ICU Medical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: US$1.35 loss per share (vs US$0.30 profit in 3Q 2023)

ICU Medical, Inc. to Report Q3, 2024 Results on Nov 12, 2024

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings released: US$1.63 loss per share (vs US$0.41 loss in 1Q 2023)

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: US$1.23 loss per share (vs US$3.11 loss in FY 2022)

Recent updates

Third quarter 2024 earnings released: US$1.35 loss per share (vs US$0.30 profit in 3Q 2023)

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

ICU Medical, Inc. Revises Earnings Guidance for the Year 2024

ICU Medical, Inc. to Report Q3, 2024 Results on Nov 12, 2024

ICU Medical, Inc. Appoints Daniel Woolson as President

Insider recently sold €369k worth of stock

Now 22% undervalued

New minor risk - Share price stability

ICU Medical, Inc. Updates Earnings Guidance for the Fiscal Year 2024

Insufficient new directors

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index

Chief Operating Officer recently sold €1.2m worth of stock

First quarter 2024 earnings released: US$1.63 loss per share (vs US$0.41 loss in 1Q 2023)

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Chief Operating Officer recently sold €1.3m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings released: US$1.23 loss per share (vs US$3.11 loss in FY 2022)

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: US$0.30 (vs US$0.55 loss in 3Q 2022)

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Chief Operating Officer recently sold €825k worth of stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings released: US$0.41 loss per share (vs US$0.31 loss in 2Q 2022)

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

First quarter 2023 earnings released: US$0.41 loss per share (vs US$1.61 loss in 1Q 2022)

Now 20% undervalued after recent price drop

Full year 2022 earnings released: US$3.11 loss per share (vs US$4.86 profit in FY 2021)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

Third quarter 2022 earnings released: US$0.55 loss per share (vs US$1.47 profit in 3Q 2021)

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings released: US$0.31 loss per share (vs US$1.34 profit in 2Q 2021)

ICU Medical, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Corporate VP recently sold €125k worth of stock

First quarter 2022 earnings released: US$1.61 loss per share (vs US$1.12 profit in 1Q 2021)

ICU Medical, Inc. to Report Q1, 2022 Results on May 09, 2022

ICU Medical, Inc., Annual General Meeting, May 17, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2022

ICU Medical, Inc. Announces Executive changes, Effective March 18, 2022

ICU Medical, Inc. to Report Q4, 2021 Results on Feb 24, 2022

ICU Medical, Inc. Announces Appointment of William Seeger as Director, Member of Audit and Compliance Committee

ICU Medical, Inc. (NasdaqGS:ICUI) completed the acquisition of Smiths Medical, Inc. from Smiths Group plc (LSE:SMIN).

Insufficient new directors

Third quarter 2021 earnings released: EPS US$1.47 (vs US$1.19 in 3Q 2020)

Corporate VP recently sold €170k worth of stock

Investor sentiment improved over the past week

ICU Medical, Inc. (NasdaqGS:ICUI) entered into an agreement to acquire Smiths Medical Division from Smiths Group plc (LSE:SMIN) for $2.5 billion.

ICU Medical, Inc. Issues Voluntary Nationwide Recall of Aminosyn II 15%, an Amino Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter

ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2021

Second quarter 2021 earnings released: EPS US$1.34 (vs US$0.91 in 2Q 2020)

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Growth Index

Independent Director recently sold €251k worth of stock

Corporate VP recently sold €162k worth of stock

First quarter 2021 earnings released: EPS US$1.12 (vs US$0.81 in 1Q 2020)

Independent Director recently sold €257k worth of stock

Full year 2020 earnings released: EPS US$4.16 (vs US$4.90 in FY 2019)

ICU Medical, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: €178

New 90-day high: €174

Revenue beats expectations